Skip to main content
FinSpry Logo
FinSpry
ALKS logo
ALKS
(NASDAQ)
Alkermes plc
$34.84-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Alkermes (ALKS) Stock Price & Financial Analysis

Alkermes Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$34.31 - $35.32
52-Week High$36.48
52-Week Low$25.17
Open$34.58
Volume2.49M
Average Volume (3M)2.49M
Market Cap5.88B
Shares Outstanding168.74M
P/E Ratio (TTM)24.47
Forward P/E37.18
Price to Sales (P/S)4.01
Price to Book (P/B)3.25
EV/EBITDA14.70
Revenue (TTM)1.48B
Net Income (TTM)241.66M
Free Cash Flow (TTM)480.33M
EPS (TTM)$1.43
Profit Margin16.37%
Operating Margin17.21%
Return on Equity (ROE)13.28%
Debt to Equity0.04
50-Day MA$31.40
200-Day MA$29.70
52-Week Change7.75%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Alkermes

What is the current stock price for ALKS?

As of the latest trading session, ALKS stock trades at $34.84. The 52-week range is $25.17–$36.48, with a day range of $34.31–$35.32.

What is the P/E ratio for ALKS?

Alkermes's trailing P/E ratio is 24.5, meaning investors pay $24.5 for every $1 of annual earnings. The forward P/E is 37.2, reflecting analyst expectations for future earnings. Alkermes operates in the Healthcare sector.

Does ALKS pay dividends?

Alkermes does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ALKS?

Based on 12 analysts, the consensus for ALKS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ALKS?

Alkermes's market capitalization is $5.88B, classifying it as a mid-cap company. Alkermes operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.